$THMO
ThermoGenesis Holdings, Inc.

2015 Q3 Form 10-K Financial Statement

#000143774915017442 Filed on September 17, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 2014 Q2
Revenue $2.823M $16.04M $3.840M
YoY Change -22.76% 0.34% -7.47%
Cost Of Revenue $2.456M $11.29M $2.670M
YoY Change -0.53% 11.8% -7.61%
Gross Profit $367.0K $4.749M $1.170M
YoY Change -69.06% -19.32% -6.4%
Gross Profit Margin 13.0% 29.6% 30.47%
Selling, General & Admin $3.184M $13.67M $3.380M
YoY Change 6.28% 19.3% 25.65%
% of Gross Profit 867.57% 287.83% 288.89%
Research & Development $1.097M $5.939M $1.070M
YoY Change -25.73% 71.25% 37.18%
% of Gross Profit 298.91% 125.06% 91.45%
Depreciation & Amortization $365.0K $1.351M $400.0K
YoY Change 13.35% 36.05% 185.71%
% of Gross Profit 99.46% 28.45% 34.19%
Operating Expenses $4.281M $19.61M $4.450M
YoY Change -4.29% 31.37% 27.87%
Operating Profit -$3.914M -$14.86M -$3.280M
YoY Change 19.08% 64.37% 47.09%
Interest Expense $7.000K $14.00K $10.00K
YoY Change -170.0% 40.0% -150.0%
% of Operating Profit
Other Income/Expense, Net $29.00K $7.000K
YoY Change 222.22%
Pretax Income -$3.400M -$14.85M -$3.270M
YoY Change 3.03% 64.4% 36.25%
Income Tax -$400.0K
% Of Pretax Income
Net Earnings -$3.397M -$14.85M -$2.870M
YoY Change 3.06% 72.08% 19.58%
Net Earnings / Revenue -120.33% -92.58% -74.74%
Basic Earnings Per Share
Diluted Earnings Per Share -$17.00M -$74.25M -$15.94M
COMMON SHARES
Basic Shares Outstanding 40.62M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.560M $3.360M $14.81M
YoY Change -38.75% -77.31% 115.26%
Cash & Equivalents $6.559M $3.360M $14.81M
Short-Term Investments
Other Short-Term Assets $130.0K $160.0K $220.0K
YoY Change -73.47% -27.27% -4.35%
Inventory $3.971M $4.600M $5.606M
Prepaid Expenses
Receivables $3.648M $5.130M $4.693M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.31M $13.25M $25.33M
YoY Change -33.32% -47.69% 55.67%
LONG-TERM ASSETS
Property, Plant & Equipment $3.196M $2.940M $2.298M
YoY Change 23.88% 27.83% 3.98%
Goodwill $13.20M $13.25M
YoY Change
Intangibles $21.16M $21.93M
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.00K $80.00K $81.00K
YoY Change -2.5% 0.0% 62.0%
Total Long-Term Assets $37.63M $37.51M $37.56M
YoY Change -0.22% -0.13% 1561.99%
TOTAL ASSETS
Total Short-Term Assets $14.31M $13.25M $25.33M
Total Long-Term Assets $37.63M $37.51M $37.56M
Total Assets $51.94M $50.76M $62.89M
YoY Change -12.23% -19.29% 239.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.650M $5.080M $3.590M
YoY Change 87.71% 41.5% 15.43%
Accrued Expenses $620.0K $710.0K $600.0K
YoY Change 31.91% 18.33% 25.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.899M $7.950M $6.380M
YoY Change 56.67% 24.61% 23.88%
LONG-TERM LIABILITIES
Long-Term Debt $20.00K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $267.0K $270.0K $169.0K
YoY Change 11.25% 58.82% 181.67%
Total Long-Term Liabilities $267.0K $270.0K $169.0K
YoY Change 11.25% 58.82% 181.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.899M $7.950M $6.380M
Total Long-Term Liabilities $267.0K $270.0K $169.0K
Total Liabilities $19.68M $15.86M $14.19M
YoY Change 45.01% 11.77% 172.36%
SHAREHOLDERS EQUITY
Retained Earnings -$141.1M -$122.8M
YoY Change
Common Stock $41.00K $40.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.26M $34.90M $48.70M
YoY Change
Total Liabilities & Shareholders Equity $51.94M $50.76M $62.89M
YoY Change -12.23% -19.29% 239.38%

Cashflow Statement

Concept 2015 Q3 2015 2014 Q2
OPERATING ACTIVITIES
Net Income -$3.397M -$14.85M -$2.870M
YoY Change 3.06% 72.08% 19.58%
Depreciation, Depletion And Amortization $365.0K $1.351M $400.0K
YoY Change 13.35% 36.05% 185.71%
Cash From Operating Activities -$1.305M -$10.65M -$1.740M
YoY Change -64.59% 35.9% 200.0%
INVESTING ACTIVITIES
Capital Expenditures $187.0K $587.0K -$70.00K
YoY Change -44.84% 46.02% 40.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$187.0K -$587.0K -$80.00K
YoY Change -44.84% 1050.98% 60.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.000K $129.0K $10.10M
YoY Change -90.91% -100.81%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.701M -189.0K 10.06M
YoY Change -8647.27% -101.2% -100700.0%
NET CHANGE
Cash From Operating Activities -1.305M -10.65M -1.740M
Cash From Investing Activities -187.0K -587.0K -80.00K
Cash From Financing Activities 4.701M -189.0K 10.06M
Net Change In Cash 3.209M -11.43M 8.240M
YoY Change -178.67% -244.26% -1387.5%
FREE CASH FLOW
Cash From Operating Activities -$1.305M -$10.65M -$1.740M
Capital Expenditures $187.0K $587.0K -$70.00K
Free Cash Flow -$1.492M -$11.24M -$1.670M
YoY Change -62.92% 36.39% 215.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40616730
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q4 dei Entity Public Float
EntityPublicFloat
30860000
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 kool Automatic Renewal Period Under Sale And Purchase Agreement
AutomaticRenewalPeriodUnderSaleAndPurchaseAgreement
P2Y
CY2015 kool Effective Income Tax Rate Reconciliation Expiration Of Ca Nols
EffectiveIncomeTaxRateReconciliationExpirationOfCANols
616000
CY2014 kool Effective Income Tax Rate Reconciliation Expiration Of Ca Nols
EffectiveIncomeTaxRateReconciliationExpirationOfCANols
CY2015 kool Effective Income Tax Rate Reconciliation Merger Costs Amount
EffectiveIncomeTaxRateReconciliationMergerCostsAmount
CY2014 kool Effective Income Tax Rate Reconciliation Merger Costs Amount
EffectiveIncomeTaxRateReconciliationMergerCostsAmount
757000
CY2015 kool Effective Income Tax Rate Reconciliation Unbenefitted Net Operating Losses And Credits Amount
EffectiveIncomeTaxRateReconciliationUnbenefittedNetOperatingLossesAndCreditsAmount
5091000
CY2014 kool Effective Income Tax Rate Reconciliation Unbenefitted Net Operating Losses And Credits Amount
EffectiveIncomeTaxRateReconciliationUnbenefittedNetOperatingLossesAndCreditsAmount
2163000
CY2015 kool Equipment Acquired By Capital Lease
EquipmentAcquiredByCapitalLease
208000
CY2015Q2 kool Future Amortization Expense Finite Lived Intangible Assets
FutureAmortizationExpenseFiniteLivedIntangibleAssets
1425000
CY2014 kool Issuance Of Common Shares For Repayment Of Related Party Notes Payable Value
IssuanceOfCommonSharesForRepaymentOfRelatedPartyNotesPayableValue
187000
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Entity Registrant Name
EntityRegistrantName
CESCA THERAPEUTICS INC.
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000811212
CY2015 kool Maximum Period Of Agreement
MaximumPeriodOfAgreement
P21Y
CY2015 kool Non Renewal Period Under Sale And Purchase Agreement
NonRenewalPeriodUnderSaleAndPurchaseAgreement
P180D
CY2015 kool Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
3
CY2015Q2 kool Short Term Investment Minimum
ShortTermInvestmentMinimum
2000000
CY2014 kool Stock Issued During Period Value New Issues Private Placement
StockIssuedDuringPeriodValueNewIssuesPrivatePlacement
5943000
CY2015Q2 kool Tax Benefits Related To Stock Options Included In Valuation Allowance
TaxBenefitsRelatedToStockOptionsIncludedInValuationAllowance
1804000
CY2015 kool Term Of The Agreement
TermOfTheAgreement
P5Y
CY2015 kool Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
539000
CY2014 kool Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
99000
CY2015Q2 kool Working Capital
WorkingCapital
5305000
CY2014Q2 kool Working Capital
WorkingCapital
18947000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5079000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3590000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5133000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4693000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4935000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4099000
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
58000
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
172540000
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
171422000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
209000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
660000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
458000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
174000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9466246
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7185252
CY2015Q2 us-gaap Assets
Assets
50757000
CY2014Q2 us-gaap Assets
Assets
62888000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
13251000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
25327000
CY2014 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1958000
CY2014 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
351000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3357000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14811000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6884000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11454000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7927000
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.55
CY2014Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1995000
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42408000
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
37317000
CY2015Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7641000
CY2014Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7641000
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2014Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1750000
CY2015Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2143000
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.81
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2259000
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1668400
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40501730
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40200529
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40501730
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40200529
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
41000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
40000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14915000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8573000
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Credit Risk</div></div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company&#x2019;s customers. The Company believes that adequate </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has not experienced significant credit related losses.</div></div></div></div></div>
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
11293000
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
10101000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-403000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
635000
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
638000
CY2015Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
916000
CY2015Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
447000
CY2014Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
582000
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38317000
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34154000
CY2015Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1479000
CY2015Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8088000
CY2014Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8223000
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2015 us-gaap Depreciation
Depreciation
850000
CY2014 us-gaap Depreciation
Depreciation
788000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1351000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
993000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-29000
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
705000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
599000
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
CY2014 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y
CY2015 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75
CY2015 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.015
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.011
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
591000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
174000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
53000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
448000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
83000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
201000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
273000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
367000
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2016000
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2232000
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1425000
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2058000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10695000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8490000
CY2014Q1 us-gaap Goodwill
Goodwill
13195000
CY2015Q2 us-gaap Goodwill
Goodwill
13195000
CY2014Q2 us-gaap Goodwill
Goodwill
13254000
CY2015 us-gaap Gross Profit
GrossProfit
4749000
CY2014 us-gaap Gross Profit
GrossProfit
5886000
CY2015 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
117000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14852000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9034000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-403000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5046000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3072000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
75000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-649000
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-326000
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1410000
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-295000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
459000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-515000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
43000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
282000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
105000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
96000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-416000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1279000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9000
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-81000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
152000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-53000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-64000
CY2015Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21886000
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22102000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21295000
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21928000
CY2015Q2 us-gaap Inventory Net
InventoryNet
4598000
CY2014Q2 us-gaap Inventory Net
InventoryNet
5606000
CY2015Q2 us-gaap Liabilities
Liabilities
15855000
CY2014Q2 us-gaap Liabilities
Liabilities
14190000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50757000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62888000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7946000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6380000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-189000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15807000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-587000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10649000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7836000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-14852000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-8631000
CY2015 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015 us-gaap Operating Expenses
OperatingExpenses
19608000
CY2014 us-gaap Operating Expenses
OperatingExpenses
14926000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-14859000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-9040000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2651000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
501000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
315000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
629000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
665000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
541000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
652000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
496000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
79000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
81000
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-63000
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
58000
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-63000
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58000
CY2015 us-gaap Other Income
OtherIncome
7000
CY2014 us-gaap Other Income
OtherIncome
6000
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1527000
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1553000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
268000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
169000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
129000
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
68000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
587000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
402000
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
163000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
217000
CY2014Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10100000
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5900000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16004000
CY2015Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5500000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21000
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
498000
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
489000
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
627000
CY2015 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
168000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137674000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122822000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
16042000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
15987000
CY2014 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
104000
CY2015 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
39000
CY2014 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-59000
CY2015 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
258000
CY2014 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
172000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7872000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6397000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2937000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2298000
CY2015 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
60000
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
150000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5939000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3468000
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2974000
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2968000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1247000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
679000
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.62
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.15
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.50
CY2014Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2
CY2014 us-gaap Stock Issued1
StockIssued1
187000
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7530000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3336800
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2014 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
27130000
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
68000
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10061000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
334000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
414000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
34902000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
48698000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
13318000
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but not limited to, the allowance for doubtful accounts, slow-moving inventory reserves, depreciation, warranty costs, assumptions made in valuing equity instruments issued for services or acquisitions and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company&#x2019;s consolidated financial statements. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying consolidated financial statements through the date of issuance.</div></div></div></div></div>
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5091
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40351946
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24234348

Files In Submission

Name View Source Status
0001437749-15-017442-index-headers.html Edgar Link pending
0001437749-15-017442-index.html Edgar Link pending
0001437749-15-017442.txt Edgar Link pending
0001437749-15-017442-xbrl.zip Edgar Link pending
a2.jpg Edgar Link pending
a3.jpg Edgar Link pending
a4.jpg Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kool-20150630.xml Edgar Link completed
kool-20150630.xsd Edgar Link pending
kool-20150630_cal.xml Edgar Link unprocessable
kool-20150630_def.xml Edgar Link unprocessable
kool-20150630_lab.xml Edgar Link unprocessable
kool-20150630_pre.xml Edgar Link unprocessable
kool20150630_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending